Johnson & Johnson cuts full-year guidance on strong dollar

johnson and johnson reported a decline in profit for the latest quarter and cut its full-year sales and profit guidance, as a strong US dollarMacroeconomic pressures and the COVID-19 pandemic impacted the health-products company’s results.

The New Brunswick, NJ-based company that makes Tylenol and Band-Aid said Tuesday Inflation has contributed to the increase in its cost For commodities, including raw materials and transportation, that cut its gross profit margin for the second quarter.